|
1
|
Rönnblom L and Pascual V: The innate
immune system in SLE: Type I interferons and dendritic cells.
Lupus. 17:394–399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mackay M, Stanevsky A, Wang T, Aranow C,
Li M, Koenig S, Ravetch JV and Diamond B: Selective dysregulation
of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med.
203:2157–2164. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Faurschou M, Starklint H, Halberg P and
Jacobsen S: Prognostic factors in lupus nephritis: Diagnostic and
therapeutic delay increases the risk of terminal renal failure. J
Rheumatol. 33:1563–1569. 2006.PubMed/NCBI
|
|
4
|
Bajaj S, Albert L, Gladman DD, Urowitz MB,
Hallett DC and Ritchie S: Serial renal biopsy in systemic lupus
erythematosus. J Rheumatol. 27:2822–2826. 2000.PubMed/NCBI
|
|
5
|
Ramos-Casals M, Nardi N, Lagrutta M,
Brito-Zerón P, Bové A, Delgado G, Cervera R, Ingelmo M and Font J:
Vasculitis in systemic lupus erythematosus: Prevalence and clinical
characteristics in 670 patients. Medicine (Baltimore). 85:95–104.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heimovski FE, Simioni JA and Skare TL:
Systemic lupus erythematosus and Raynaud's phenomenon. An Bras
Dermatol. 90:837–840. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
D'Cruz DP, Mellor-Pita S, Joven B, Sanna
G, Allanson J, Taylor J, Khamashta MA and Hughes GR: Transverse
myelitis as the first manifestation of systemic lupus erythematosus
or lupus-like disease: Good functional outcome and relevance of
antiphospholipid antibodies. J Rheumatol. 31:280–285.
2004.PubMed/NCBI
|
|
8
|
Lin H, Lee E, Hestir K, Leo C, Huang M,
Bosch E, Halenbeck R, Wu G, Zhou A, Behrens D, et al: Discovery of
a cytokine and its receptor by functional screening of the
extracellular proteome. Science. 320:807–811. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Foucher ED, Blanchard S, Preisser L, Garo
E, Ifrah N, Guardiola P, Delneste Y and Jeannin P: IL-34 induces
the differentiation of human monocytes into immunosuppressive
macrophages. antagonistic effects of GM-CSF and IFNγ. PLoS One.
8:e560452013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chalmers SA, Chitu V, Ramanujam M and
Putterman C: Therapeutic targeting of macrophages in lupus
nephritis. Discov Med. 20:43–49. 2015.PubMed/NCBI
|
|
11
|
Roussel L, Houle F, Chan C, Yao Y, Bérubé
J, Olivenstein R, Martin JG, Huot J, Hamid Q, Ferri L, et al: IL-17
promotes p38 MAPK-dependent endothelial activation enhancing
neutrophil recruitment to sites of inflammation. J Immunol.
184:4531–4537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao XF, Pan HF, Yuan H, Zhang WH, Li XP,
Wang GH, Wu GC, Su H, Pan FM, Li WX, et al: Increased serum
interleukin 17 in patients with systemic lupus erythematosus. Mol
Biol Rep. 37:81–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsu HC, Yang P, Wang J, Wu Q, Myers R,
Chen J, Yi J, Guentert T, Tousson A, Stanus AL, et al: Interleukin
17-producing T helper cells and interleukin 17 orchestrate
autoreactive germinal center development in autoimmune BXD2 mice.
Nat Immunol. 9:166–175. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sprangers B, Monahan M and Appel GB:
Diagnosis and treatment of lupus nephritis flares - an update. Nat
Rev Nephrol. 8:709–717. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mok CC, Ying KY, Tang S, Leung CY, Lee KW,
Ng WL, Wong RW and Lau CS: Predictors and outcome of renal flares
after successful cyclophosphamide treatment for diffuse
proliferative lupus glomerulonephritis. Arthritis Rheum.
50:2559–2568. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saxena R, Mahajan T and Mohan C: Lupus
nephritis: Current update. Arthritis Res Ther. 13:2402011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Balow JE, Waldman M and Austin HA: Lupus
nephritis. Therapy in Nephrology & Hypertension. Saunders;
Philadelphia, PA: pp. 157–171. 2008, View Article : Google Scholar
|
|
18
|
Bethunaickan R, Berthier CC, Zhang W,
Kretzler M and Davidson A: Comparative transcriptional profiling of
3 murine models of SLE nephritis reveals both unique and shared
regulatory networks. PLoS One. 8:e774892013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Susianti H, Iriane VM, Dharmanata S,
Handono K, Widijanti A, Gunawan A and Kalim H: Analysis of urinary
TGF-β1, MCP-1, NGAL, and IL-17 as biomarkers for lupus nephritis.
Pathophysiology. 22:65–71. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Menke J, Rabacal WA, Byrne KT, Iwata Y,
Schwartz MM, Stanley ER, Schwarting A and Kelley VR: Circulating
CSF-1 promotes monocyte and macrophage phenotypes that enhance
lupus nephritis. J Am Soc Nephrol. 20:2581–2592. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen K, Yu Y, Tang Z, Liu Z and Li L: The
prognosis of biopsy-proven lupus nephritis in Chinese patients:
Long term follow-up of 86 cases. Chin Med J (Engl). 110:502–507.
1997.PubMed/NCBI
|
|
22
|
Daniel L, Sichez H, Giorgi R, Dussol B,
Figarella-Branger D, Pellissier JF and Berland Y: Tubular lesions
and tubular cell adhesion molecules for the prognosis of lupus
nephritis. Kidney Int. 60:2215–2221. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nee R, Jindal RM, Little D, Ramsey-Goldman
R, Agodoa L, Hurst FP and Abbott KC: Racial differences and income
disparities are associated with poor outcomes in kidney transplant
recipients with lupus nephritis. Transplantation. 95:1471–1478.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yap DY, Tang CS, Ma MK, Lam MF and Chan
TM: Survival analysis and causes of mortality in patients with
lupus nephritis. Nephrol Dial Transplant. 27:3248–3254. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sánchez-Lozada LG, Tapia E, López-Molina
R, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ,
Herrera-Acosta J and Franco M: Effects of acute and chronic
L-arginine treatment in experimental hyperuricemia. Am J Physiol
Renal Physiol. 292:F1238–F1244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu T, Fu Y, Brekken D, Yan M, Zhou XJ,
Vanarsa K, Deljavan N, Ahn C, Putterman C and Mohan C: Urine
proteome scans uncover total urinary protease, PGDS, SAP and SOD as
potential markers of lupus nephritis. J Immunol. 184:2183–2193.
2010. View Article : Google Scholar : PubMed/NCBI
|
